A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia
10.1080/17512433.2023.2274538
Saved in:
Main Authors: | Jie Wu, Angela T.H. Kwan, Taeho Greg Rhee, Roger C M Ho, Giacomo d'Andrea, Giovanni Martinotti, Kayla M. Teopiz, Felicia Ceban, Roger McIntyre |
---|---|
Other Authors: | PSYCHOLOGICAL MEDICINE |
Format: | Article |
Published: |
Taylor & Francis
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/246441 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Effects of Cannabidiol and Δ9-tetrahydrocannabinol on Cytochrome P450 Enzymes: A Systematic Review
by: Sarah Smith, et al.
Published: (2024) -
Efficacy of dextromethorphan for the treatment of depression: A systematic review of preclinical and clinical trials
by: Amna Majeed, et al.
Published: (2021) -
Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder
by: Renee-Marie Ragguett, et al.
Published: (2018) -
Hallucinogen Persisting Perceptual Disorder: A Scoping Review Covering Frequency, Risk Factors, Prevention and Treatment
by: Marcus A. Doyle, et al.
Published: (2022) -
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis
by: Kayla M. Teopiz, et al.
Published: (2024)